This company has been marked as potentially delisted and may not be actively trading. Eidos Therapeutics (EIDX) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Eidos-Montreal lays off staff, citing inability to transfer them to new projectsMarch 31, 2025 | venturebeat.comTomb Raider Developer Eidos Montreal Hit With LayoffsMarch 31, 2025 | msn.comEidos Montreal lays off more employees: 'We don’t have the capacity to entirely reallocate them to our other ongoing projects'March 31, 2025 | msn.comNext Deus Ex game seemingly canceled as Eidos Montreal is affected by layoffsNovember 3, 2024 | msn.comStellar Blade: How To Drain Water In Eidos 7 (Oblivion Side Quest)May 7, 2024 | msn.comStellar Blade: How to Solve Monorail Puzzle on Eidos 7April 26, 2024 | msn.comThe Anglo File: Game Over for Board Lapses at EidosFebruary 3, 2024 | thestreet.comDeus Ex game canceled as nearly 100 Eidos-Montreal staff laid offJanuary 31, 2024 | msn.comEmbracer Group reportedly cancels unannounced Deus Ex game, lays off staff at Eidos MontrealJanuary 31, 2024 | msn.comEmbracer lays off 97 Eidos employees and cancels new Deus Ex gameJanuary 31, 2024 | msn.comEidos Therapeutics Inc (EIDX)July 16, 2023 | investing.comVTGN - Vistagen Therapeutics, Inc.June 27, 2023 | finance.yahoo.comEidos' Guardians of the Galaxy Can Still Ride the Wave of Volume 3's May ReleaseApril 7, 2023 | msn.comCara Therapeutics Stock (NASDAQ:CARA), Quotes and News SummaryFebruary 24, 2023 | benzinga.comAdvanced Proteome Therapeutics Corp.: Advanced Proteome Therapeutics Announces Closing of Non-Brokered Private PlacementDecember 28, 2022 | finanznachrichten.deSony Eyeing Square Enix Tokyo Purchase Months After Crystal Dynamics, Eidos Montreal SaleJuly 28, 2022 | msn.comSony wants to buy Square Enix Tokyo claims Eidos-Montréal founderJuly 26, 2022 | msn.comThe Eidos games that could be revived with the Embracer acquisitionMay 2, 2022 | msn.comEmbracer agrees to buy Crystal Dynamics, Eidos-Montréal, Square Enix Montréal, and their IPMay 2, 2022 | venturebeat.comVideo-game studio Eidos-Montreal is switching to a 4-day work week for its staff, cutting weekly hours from 40 to 32 while keeping salaries the sameOctober 8, 2021 | msn.comEidos-Montréal gambles with entry into "Guardians of the Galaxy" franchiseSeptember 22, 2021 | news.yahoo.comEidos Therapeutics, Inc. Common Stock (EIDX)July 24, 2021 | nasdaq.com Get Eidos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EIDX and its competitors with MarketBeat's FREE daily newsletter. Email Address EIDX Media Mentions By Week EIDX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EIDX News Sentiment▼0.000.74▲Average Medical News Sentiment EIDX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EIDX Articles This Week▼00▲EIDX Articles Average Week Get Eidos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EIDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Summit Therapeutics News Today Royalty Pharma News Today Teva Pharmaceutical Industries News Today Intra-Cellular Therapies News Today Genmab A/S News Today United Therapeutics News Today Insmed News Today Dr. Reddy's Laboratories News Today BioMarin Pharmaceutical News Today Ascendis Pharma A/S News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EIDX) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisisWhat's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot...Stansberry Research | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eidos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eidos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EIDX Stock Free EIDX Stock Alerts